In his 2015 State of the Union address, President Obama announced the launch of a landmark longitudinal Precision Medicine Initiative (PMI) Cohort Program. An unprecedented nationwide genomic research study, the NIH-led PMI aims to enroll 1 million people to improve our ability to prevent and treat disease based on individual lifestyle, environment and genetics.
NorthShore’s Research Institute will be playing a major role in this effort. A member of the Illinois Precision Medicine Consortium (IPMC), NorthShore will enroll over 9,000 NorthShore patients in the study. The IPMC is part of a wider $55 million federal set of awards under the PMI. Pablo Gejman, MD, serves as the principal investigator of the NorthShore IPMC site and as a member of the IPMC’s Steering Committee and Emerging Scientific Opportunities Committee. Participants in NorthShore’s PMI will be asked to share a wide-range of health, environmental and lifestyle information. Additionally, they will contribute blood and urine samples, and grant access to their electronic health records. Mobile health devices and apps will provide lifestyle data and environmental exposures in real time.